In contexts where high BK current densities in striatal cholinergic neurons are associated with hyperexcitability of cholinergic neurons, the novel CDK5 activator may provide an intervention target to suppress dyskinesia-like behaviors in neurological disorders. The gene discussed is CDK5; the disease is nervous system disorder.